Recipient priming to one RBC alloantigen directly enhances subsequent alloimmunization in mice

Blood Advances

Volumn 2, Issue 2, 2018, Pages 105-115

  Patel, Seema R ^a   Bennett, Ashley ^a   Girard Pierce, Kathryn ^a   Maier, Cheryl L ^a   Chonat, Satheesh ^a   Arthur, Connie M ^a   Zerra, Patricia E ^a   Mener, Amanda ^a   Stowell, Sean R ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; BLOOD GROUP ANTIGEN; GLYCOPHORIN A ANTIBODY; HOD ANTIBODY; HOD ANTIGEN; KELL BLOOD GROUP ANTIGEN; OVALBUMIN; POLYINOSINIC POLYCYTIDYLIC ACID; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; ALLOANTIBODY;

ADOPTIVE TRANSFER; ALLOIMMUNIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CROSS PRESENTATION; ERYTHROCYTE TRANSFUSION; FEMALE; GRAFT RECIPIENT; HUMORAL IMMUNITY; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; T CELL DEPLETION; ANIMAL; ERYTHROCYTE; IMMUNOLOGY; MOUSE;

ANIMALS; ANTIBODY FORMATION; CD4-POSITIVE T-LYMPHOCYTES; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; IMMUNITY, HUMORAL; ISOANTIBODIES; ISOANTIGENS; MICE;

EID: 85050304586     PISSN: 24739529     EISSN: 24739537     Source Type: Journal    
DOI: 10.1182/bloodadvances.2017010124     Document Type: Article

References (65)

1. Vichinsky EP, Earles A, Johnson RA, Hoag MS, Williams A, Lubin B. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med. 1990;322(23):1617-1621.
2. Higgins JM, Sloan SR. Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders. Blood. 2008;112(6):2546-2553.
3. Schonewille H, Haak HL, van Zijl AM. Alloimmunization after blood transfusion in patients with hematologic and oncologic diseases. Transfusion. 1999;39(7):763-771.
4. Telen MJ, Afenyi-Annan A, Garrett ME, Combs MR, Orringer EP, Ashley-Koch AE. Alloimmunization in sickle cell disease: changing antibody specificities and association with chronic pain and decreased survival. Transfusion. 2015;55(6 Pt 2):1378-1387.
5. Nickel RS, Hendrickson JE, Fasano RM, et al. Impact of red blood cell alloimmunization on sickle cell disease mortality: a case series. Transfusion. 2016; 56(1):107-114.
6. Castro O, Sandler SG, Houston-Yu P, Rana S. Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications. Transfusion. 2002;42(6):684-690.
7. Aygun B, Padmanabhan S, Paley C, Chandrasekaran V. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion. 2002;42(1):37-43.
8. Fasano RM, Booth GS, Miles M, et al. Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease. Br J Haematol. 2015;168(2):291-300.
9. Papay P, Hackner K, Vogelsang H, et al. High risk of transfusion-induced alloimmunization of patients with inflammatory bowel disease. Am J Med. 2012;125(7):e711-e718.
10. Ryder AB, Hendrickson JE, Tormey CA. Chronic inflammatory autoimmune disorders are a risk factor for red blood cell alloimmunization. Br J Haematol. 2016;174(3):483-485.
11. Godefroy E, Liu Y, Shi P, et al. Altered heme-mediated modulation of dendritic cell function in sickle cell alloimmunization. Haematologica. 2016;101(9): 1028-1038.
12. Zhong H, Bao W, Friedman D, Yazdanbakhsh K. Hemin controls T cell polarization in sickle cell alloimmunization. J Immunol. 2014;193(1):102-110.
13. Vingert B, Tamagne M, Habibi A, et al. Phenotypic differences of CD4(1) T cells in response to red blood cell immunization in transfused sickle cell disease patients. Eur J Immunol. 2015;45(6):1868-1879.
14. Bao W, Zhong H, Manwani D, et al. Regulatory B-cell compartment in transfused alloimmunized and non-alloimmunized patients with sickle cell disease. Am J Hematol. 2013;88(9):736-740.
15. Godefroy E, Zhong H, Pham P, Friedman D, Yazdanbakhsh K. TIGIT-positive circulating follicular helper T cells display robust B-cell help functions: potential role in sickle cell alloimmunization. Haematologica. 2015;100(11):1415-1425.
16. Stephen J, Cairns LS, Pickford WJ, Vickers MA, Urbaniak SJ, Barker RN. Identification, immunomodulatory activity, and immunogenicity of the major helper T-cell epitope on the K blood group antigen. Blood. 2012;119(23):5563-5574.
17. Stott LM, Barker RN, Urbaniak SJ. Identification of alloreactive T-cell epitopes on the Rhesus D protein. Blood. 2000;96(13):4011-4019.
18. Chiaroni J, Dettori I, Ferrera V, et al. HLA-DRB1 polymorphism is associated with Kell immunisation. Br J Haematol. 2006;132(3):374-378.
19. Noizat-Pirenne F, Tournamille C, Bierling P, et al. Relative immunogenicity of Fya and K antigens in a Caucasian population, based on HLA class II restriction analysis. Transfusion. 2006;46(8):1328-1333.
20. Reviron D, Dettori I, Ferrera V, et al. HLA-DRB1 alleles and Jk(a) immunization. Transfusion. 2005;45(6):956-959.
21. Maluskova A, Mrazek F, Pauliskova M, et al. Association of HLA-DRB1 and HLA-DQB1 with red-blood-cell alloimmunization in the Czech population. Vox Sang. 2017;112(2):156-162.
22. Picard C, Frassati C, Basire A, et al. Positive association of DRB1 04 and DRB1 15 alleles with Fya immunization in a Southern European population. Transfusion. 2009;49(11):2412-2417.
23. Baleotti W Jr, Ruiz MO, Fabron A Jr, Castilho L, Giuliatti S, Donadi EA. HLA-DRB1∗07:01 allele is primarily associated with the Diego a alloimmunization in a Brazilian population. Transfusion. 2014;54(10):2468-2476.
24. Chu CC, Ho HT, Lee HL, et al. Anti-"Mi(a)" immunization is associated with HLA-DRB1∗0901. Transfusion. 2009;49(3):472-478.
25. Schonewille H, Doxiadis II, Levering WH, Roelen DL, Claas FH, Brand A. HLA-DRB1 associations in individuals with single and multiple clinically relevant red blood cell antibodies. Transfusion. 2014;54(8):1971-1980.
26. Sippert EA, Visentainer JE, Alves HV, et al. Red blood cell alloimmunization in patients with sickle cell disease: correlation with HLA and cytokine gene polymorphisms. Transfusion. 2017;57(2):379-389.
27. Calabro S, Gallman A, Gowthaman U, et al. Bridging channel dendritic cells induce immunity to transfused red blood cells. J Exp Med. 2016;213(6): 887-896.
28. Desmarets M, Cadwell CM, Peterson KR, Neades R, Zimring JC. Minor histocompatibility antigens on transfused leukoreduced units of red blood cells induce bone marrow transplant rejection in a mouse model. Blood. 2009;114(11):2315-2322.
29. Lanzavecchia A. Antigen-specific interaction between T and B cells. Nature. 1985;314(6011):537-539.
30. Mitchison NA. The carrier effect in the secondary response to hapten-protein conjugates. II. Cellular cooperation. Eur J Immunol. 1971;1(1):18-27.
31. Smith NH, Henry KL, Cadwell CM, et al. Generation of transgenic mice with antithetical KEL1 and KEL2 human blood group antigens on red blood cells. Transfusion. 2012;52(12):2620-2630.
32. Stowell SR, Henry KL, Smith NH, et al. Alloantibodies to a paternally derived RBC KEL antigen lead to hemolytic disease of the fetus/newborn in a murine model. Blood. 2013;122(8):1494-1504.
33. Stowell SR, Arthur CM, Girard-Pierce KR, et al. Anti-KEL sera prevents alloimmunization to transfused KEL RBCs in a murine model. Haematologica. 2015;100(10):e394-e397.
34. Girard-Pierce KR, Stowell SR, Smith NH, et al. A novel role for C3 in antibody-induced red blood cell clearance and antigen modulation. Blood. 2013; 122(10):1793-1801.
35. Stowell SR, Girard-Pierce KR, Smith NH, et al. Transfusion of murine red blood cells expressing the human KEL glycoprotein induces clinically significant alloantibodies. Transfusion. 2014;54(1):179-189.
36. Smith NH, Hod EA, Spitalnik SL, Zimring JC, Hendrickson JE. Transfusion in the absence of inflammation induces antigen-specific tolerance to murine RBCs. Blood. 2012;119(6):1566-1569.
37. Liepkalns JS, Hod EA, Stowell SR, Cadwell CM, Spitalnik SL, Zimring JC. Biphasic clearance of incompatible red blood cells through a novel mechanism requiring neither complement nor Fcg receptors in a murine model. Transfusion. 2012;52(12):2631-2645.
38. Auffray I, Marfatia S, de Jong K, et al. Glycophorin A dimerization and band 3 interaction during erythroid membrane biogenesis: in vivo studies in human glycophorin A transgenic mice. Blood. 2001;97(9):2872-2878.
39. Arthur CM, Patel SR, Smith NH, et al. Antigen density dictates immune responsiveness following red blood cell transfusion. J Immunol. 2017;198(7): 2671-2680.
40. Hendrickson JE, Roback JD, Hillyer CD, Easley KA, Zimring JC. Discrete Toll-like receptor agonists have differential effects on alloimmunization to transfused red blood cells. Transfusion. 2008;48(9):1869-1877.
41. Hendrickson JE, Desmarets M, Deshpande SS, et al. Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells. Transfusion. 2006;46(9):1526-1536.
42. Hendrickson JE, Chadwick TE, Roback JD, Hillyer CD, Zimring JC. Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells. Blood. 2007;110(7):2736-2743.
43. Hendrickson JE, Hod EA, Perry JR, et al. Alloimmunization to transfused HOD red blood cells is not increased in mice with sickle cell disease. Transfusion. 2012;52(2):231-240.
44. Patel SR, Smith NH, Kapp L, Zimring JC. Mechanisms of alloimmunization and subsequent bone marrow transplantation rejection induced by platelet transfusion in a murine model. Am J Transplant. 2012;12(5):1102-1112.
45. Stowell SR, Girard-Pierce KR, Arthur CM, Smith NH, Zimring JC, Hendrickson JE. KEL RBC transfusion induces IgG anti-KEL antibodies independent of CD4 T cells. Blood. 2013;122(21):41.
46. Hendrickson JE, Saakadze N, Cadwell CM, et al. The spleen plays a central role in primary humoral alloimmunization to transfused mHEL red blood cells. Transfusion. 2009;49(8):1678-1684.
47. Arthur CM, Patel SR, Sullivan HC, et al. CD81 T cells mediate antibody-independent platelet clearance in mice. Blood. 2016;127(14):1823-1827.
48. Sullivan HC, Gerner-Smidt C, Nooka AK, et al. Daratumumab (anti-CD38) induces loss of CD38 on red blood cells. Blood. 2017;129(22):3033-3037.
49. Hudson KE, Lin E, Hendrickson JE, Lukacher AE, Zimring JC. Regulation of primary alloantibody response through antecedent exposure to a microbial T-cell epitope. Blood. 2010;115(19):3989-3996.
50. Hudson KE, Hendrickson JE, Cadwell CM, Iwakoshi NN, Zimring JC. Partial tolerance of autoreactive B and T cells to erythrocyte-specific self-antigens in mice. Haematologica. 2012;97(12):1836-1844.
51. Barnden MJ, Allison J, Heath WR, Carbone FR. Defective TCR expression in transgenic mice constructed using cDNA-based alpha-and beta-chain genes under the control of heterologous regulatory elements. Immunol Cell Biol. 1998;76(1):34-40.
52. Natarajan P, Liu D, Patel SR, et al. CD4 Depletion or CD40L Blockade Results in Antigen-Specific Tolerance in a Red Blood Cell Alloimmunization Model. Front Immunol. 2017;8:907.
53. Fehr T, Skrastina D, Pumpens P, Zinkernagel RM. T cell-independent type I antibody response against B cell epitopes expressed repetitively on recombinant virus particles. Proc Natl Acad Sci USA. 1998;95(16):9477-9481.
54. Vos Q, Lees A, Wu ZQ, Snapper CM, Mond JJ. B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms. Immunol Rev. 2000;176(1):154-170.
55. Tyler LN, Harville TO, Blackall DP. Multiple alloantibodies after transfusion in an infant treated with infliximab. N Engl J Med. 2007;357(20): 2092-2093, discussion 2093.
56. Ramsey G, Smietana SJ. Multiple or uncommon red cell alloantibodies in women: association with autoimmune disease. Transfusion. 1995;35(7): 582-586.
57. Hata JL, Johnson MS, Booth GS. Neonatal alloimmunization: a rare case of multiple alloantibody formation in a patient with disseminated histoplasmosis. Transfusion. 2013;53(5):1140-1141.
58. Evers D, van der Bom JG, Tijmensen J, et al. Red cell alloimmunisation in patients with different types of infections. Br J Haematol. 2016;175(5):956-966.
59. Brantley SG, Ramsey G. Red cell alloimmunization in multitransfused HLA-typed patients. Transfusion. 1988;28(5):463-466.
60. Yu J, Heck S, Yazdanbakhsh K. Prevention of red cell alloimmunization by CD25 regulatory T cells in mouse models. Am J Hematol. 2007;82(8):691-696.
61. Bao W, Yu J, Heck S, Yazdanbakhsh K. Regulatory T-cell status in red cell alloimmunized responder and nonresponder mice. Blood. 2009;113(22): 5624-5627.
62. Mitchison NA. The discovery of T cell-B cell cooperation. Front Immunol. 2014;5:377.
63. Scherle PA, Gerhard W. Functional analysis of influenza-specific helper T cell clones in vivo. T cells specific for internal viral proteins provide cognate help for B cell responses to hemagglutinin. J Exp Med. 1986;164(4):1114-1128.
64. Arneja A, Salazar JE, Jiang W, Hendrickson JE, Zimring JC, Luckey CJ. Interleukin-6 receptor-alpha signaling drives anti-RBC alloantibody production and T-follicular helper cell differentiation in a murine model of red blood cell alloimmunization. Haematologica. 2016;101(11):e440-e444.
65. Yazdanbakhsh K. Mechanisms of sickle cell alloimmunization. Transfus Clin Biol. 2015;22(3):178-181.